Literature DB >> 27943247

Long-Term Outcomes of Medication Intervention Using the Screening Tool of Older Persons Potentially Inappropriate Prescriptions Screening Tool to Alert Doctors to Right Treatment Criteria.

Dvora Frankenthal1, Avi Israeli1, Yoseph Caraco2, Yaffa Lerman3, Edward Kalendaryev4, Gisele Zandman-Goddard3,5, Yehuda Lerman3.   

Abstract

OBJECTIVES: To compare 24-month outcomes of participants of a prospective randomized controlled trial (RCT) assigned to undergo a medication intervention of orally communicated recommendations based on Screening Tool of Older Persons potentially inappropriate Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) (intervention group) with outcomes of those assigned to undergo written medication review (control group).
DESIGN: Retrospective cohort study.
SETTING: Chronic care geriatric facility. PARTICIPANTS: Of 359 participants from a prospective RCT conducted between April 2012 and September 2013, 306 were evaluable for another 12-month follow-up. MEASUREMENTS: Outcomes at 24-month follow-up included quality of prescribing (assessed according to STOPP/START), hospitalizations, falls, costs of medications, and all-cause mortality. Outcomes were compared with those reported at the beginning (baseline) and end (12-month follow-up) of the RCT.
RESULTS: There was a significant rise in potentially inappropriate prescriptions (PIPs) (P = .01) and potentially prescriptions omissions (PPOs) (P < .001) in the intervention group between 12 and 24 months, although the prevalence of PIPs was significantly lower in the intervention group (33.3%) than the control group (48.4%) at 24-month follow-up (P = .02). Costs of medications were significantly lower in the intervention group than the control group (P < .001) at 24-month follow-up. The average number of falls in both groups dropped significantly between baseline and study closure (P = .04 and P = .008, respectively). There was no significant difference in hospitalizations and mortality between the two groups at 24-month follow-up.
CONCLUSION: The effect of an orally communicated medication intervention with the STOPP/START criteria on falls was maintained over time. Direct communication between pharmacists and prescribing physicians is more efficient than written medication review and is recommended every 6 months in geriatric facilities.
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society.

Entities:  

Keywords:  START criteria; STOPP criteria; elderly; inappropriate prescribing

Mesh:

Year:  2016        PMID: 27943247     DOI: 10.1111/jgs.14570

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  10 in total

1.  Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.

Authors:  Shakti Shrestha; Arjun Poudel; Kathryn Steadman; Lisa Nissen
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

2.  Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study.

Authors:  Janet K Sluggett; Gillian E Caughey; Tracy Air; Max Moldovan; Catherine Lang; Grant Martin; Stephen R Carter; Shane Jackson; Andrew C Stafford; Steve L Wesselingh; Maria C Inacio
Journal:  Age Ageing       Date:  2022-07-01       Impact factor: 12.782

Review 3.  Depression, antidepressants and fall risk: therapeutic dilemmas-a clinical review.

Authors:  E P van Poelgeest; A C Pronk; D Rhebergen; N van der Velde
Journal:  Eur Geriatr Med       Date:  2021-03-15       Impact factor: 1.710

Review 4.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

Review 5.  Interventions for preventing falls in older people in care facilities and hospitals.

Authors:  Ian D Cameron; Suzanne M Dyer; Claire E Panagoda; Geoffrey R Murray; Keith D Hill; Robert G Cumming; Ngaire Kerse
Journal:  Cochrane Database Syst Rev       Date:  2018-09-07

6.  Use of Antipsychotic Drugs by Elderly Primary Care Patients and the Effects of Medication Reviews: A Cross-Sectional Study in Sweden.

Authors:  Cecilia Lenander; Patrik Midlöv; Nina Viberg; John Chalmers; Kris Rogers; Åsa Bondesson
Journal:  Drugs Real World Outcomes       Date:  2017-09

7.  Methodological Challenges for Epidemiologic Studies of Deprescribing at the End of Life.

Authors:  Jennifer Tjia; Jennifer L Lund; Deborah S Mack; Attah Mbrah; Yiyang Yuan; Qiaoxi Chen; Seun Osundolire; Cara L McDermott
Journal:  Curr Epidemiol Rep       Date:  2021-04-23

Review 8.  Effectiveness of Interventions to Reduce Potentially Inappropriate Medication in Older Patients: A Systematic Review.

Authors:  Daniela A Rodrigues; Ana I Plácido; Ramona Mateos-Campos; Adolfo Figueiras; Maria Teresa Herdeiro; Fátima Roque
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

9.  Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: a retrospective cross-sectional study.

Authors:  Junpei Komagamine
Journal:  BMJ Open       Date:  2018-07-19       Impact factor: 2.692

10.  Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.

Authors:  Tara R Earl; Nicole D Katapodis; Stephanie R Schneiderman; Sarah J Shoemaker-Hunt
Journal:  J Patient Saf       Date:  2020-09       Impact factor: 2.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.